- Home
- MMI vs TNDM Comparison
MMI vs TNDM Comparison
Compare MMI & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMI
- TNDM
- Stock Information
- Founded
- MMI 1971
- TNDM 2006
- Country
- MMI United States
- TNDM United States
- Employees
- MMI N/A
- TNDM N/A
- Industry
- MMI Real Estate
- TNDM Medical/Dental Instruments
- Sector
- MMI Finance
- TNDM Health Care
- Exchange
- MMI Nasdaq
- TNDM Nasdaq
- Market Cap
- MMI 1.2B
- TNDM 1.1B
- IPO Year
- MMI 2013
- TNDM 2013
- Fundamental
- Price
- MMI $31.76
- TNDM $17.04
- Analyst Decision
- MMI Sell
- TNDM Buy
- Analyst Count
- MMI 1
- TNDM 13
- Target Price
- MMI $30.00
- TNDM $32.92
- AVG Volume (30 Days)
- MMI 178.9K
- TNDM 1.4M
- Earning Date
- MMI 08-06-2025
- TNDM 07-31-2025
- Dividend Yield
- MMI 1.57%
- TNDM N/A
- EPS Growth
- MMI N/A
- TNDM N/A
- EPS
- MMI N/A
- TNDM N/A
- Revenue
- MMI $711,994,000.00
- TNDM $982,951,000.00
- Revenue This Year
- MMI $11.69
- TNDM $8.91
- Revenue Next Year
- MMI $24.07
- TNDM $11.04
- P/E Ratio
- MMI N/A
- TNDM N/A
- Revenue Growth
- MMI 14.79
- TNDM 27.65
- 52 Week Low
- MMI $27.61
- TNDM $15.75
- 52 Week High
- MMI $42.80
- TNDM $48.24
- Technical
- Relative Strength Index (RSI)
- MMI 51.26
- TNDM 28.98
- Support Level
- MMI $30.19
- TNDM $18.54
- Resistance Level
- MMI $31.41
- TNDM $21.18
- Average True Range (ATR)
- MMI 0.89
- TNDM 1.03
- MACD
- MMI 0.03
- TNDM -0.32
- Stochastic Oscillator
- MMI 50.46
- TNDM 16.44
About MMI Marcus & Millichap Inc.
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.